Trulieve Cannabis Statistics

Total Valuation

Trulieve Cannabis has a market cap or net worth of CAD 1.33 billion. The enterprise value is 2.01 billion.

Market Cap	1.33B
Enterprise Value	2.01B

Important Dates

The next estimated earnings date is Friday, February 28, 2025.

Earnings Date	Feb 28, 2025
Ex-Dividend Date	n/a

Share Statistics

Trulieve Cannabis has 190.95 million shares outstanding. The number of shares has increased by 0.37% in one year.

Current Share Class	n/a
Shares Outstanding	190.95M
Shares Change (YoY)	+0.37%
Shares Change (QoQ)	-0.07%
Owned by Insiders (%)	19.01%
Owned by Institutions (%)	4.66%
Float	149.90M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.83
PB Ratio	0.74
P/TBV Ratio	n/a
P/FCF Ratio	3.47
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 4.65, with an EV/FCF ratio of 5.24.

EV / Earnings	-11.53
EV / Sales	1.27
EV / EBITDA	4.65
EV / EBIT	12.12
EV / FCF	5.24

Financial Position

The company has a current ratio of 4.41, with a Debt / Equity ratio of 0.63.

Current Ratio	4.41
Quick Ratio	2.43
Debt / Equity	0.63
Debt / EBITDA	2.58
Debt / FCF	2.91
Interest Coverage	1.79

Financial Efficiency

Return on equity (ROE) is -9.53% and return on invested capital (ROIC) is 3.42%.

Return on Equity (ROE)	-9.53%
Return on Assets (ROA)	2.71%
Return on Capital (ROIC)	3.42%
Revenue Per Employee	293,286
Profits Per Employee	-32,210
Employee Count	5,400
Asset Turnover	0.42
Inventory Turnover	2.17

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +3.24% in the last 52 weeks. The beta is 1.43, so Trulieve Cannabis's price volatility has been higher than the market average.

Beta (5Y)	1.43
52-Week Price Change	+3.24%
50-Day Moving Average	11.24
200-Day Moving Average	13.63
Relative Strength Index (RSI)	35.73
Average Volume (20 Days)	318,982

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Trulieve Cannabis had revenue of CAD 1.58 billion and -173.94 million in losses. Loss per share was -0.92.

Revenue	1.58B
Gross Profit	922.13M
Operating Income	165.37M
Pretax Income	87.05M
Net Income	-173.94M
EBITDA	389.50M
EBIT	165.37M
Loss Per Share	-0.92

Full Income Statement

Balance Sheet

The company has 429.39 million in cash and 1.11 billion in debt, giving a net cash position of -682.76 million or -3.58 per share.

Cash & Cash Equivalents	429.39M
Total Debt	1.11B
Net Cash	-682.76M
Net Cash Per Share	-3.58
Equity (Book Value)	1.77B
Book Value Per Share	9.37
Working Capital	629.97M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 503.05 million and capital expenditures -120.62 million, giving a free cash flow of 382.42 million.

Operating Cash Flow	503.05M
Capital Expenditures	-120.62M
Free Cash Flow	382.42M
FCF Per Share	2.00

Full Cash Flow Statement

Margins

Gross margin is 58.22%, with operating and profit margins of 10.44% and -10.98%.

Gross Margin	58.22%
Operating Margin	10.44%
Pretax Margin	5.50%
Profit Margin	-10.98%
EBITDA Margin	24.59%
EBIT Margin	10.44%
FCF Margin	24.15%

Dividends & Yields

Trulieve Cannabis does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.37%
Shareholder Yield	-0.37%
Earnings Yield	n/a
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Trulieve Cannabis has an Altman Z-Score of 1.02. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.02
Piotroski F-Score	n/a